DANIEL TROCK: Open Payments
NPI 1639134885 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,966 in 146 payments from 35 companies in 2025. Trend: 2023 $3,078 · 2024 $3,534 · 2025 $2,966
Food & beverage: $2,966
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 16 | $302 |
| AstraZeneca Pharmaceuticals LP | 2 | $284 |
| PFIZER INC. | 15 | $234 |
| GlaxoSmithKline, LLC. | 13 | $200 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $197 |
| Novo Nordisk Inc | 11 | $192 |
| Otsuka America Pharmaceutical, Inc. | 10 | $173 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $142 |
| UCB, Inc. | 5 | $132 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $107 |
Products named: BREZTRI, JARDIANCE, REXULTI, MOUNJARO, Kerendia, TRELEGY ELLIPTA, Rystiggo, Ozempic.
Industry payments across NY — which companies pay providers there.
